Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Want to turn your skills into cash? Explore ways to monetize your skills fast and increase your income.
19,311 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
XRP sits in a tight range around $1.10 as traders await regulatory developments. A clean break above $1.20 could redr...
Two tech giants with divergent business lines are converging as tech dopplegangers, challenging investors to navigate...
Meta's push into cloud services could reshape AI compute bets. Learn how Nebius and CoreWeave investors might respond...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
TSMC delivers a record quarterly print as AI-driven demand powers growth. Margin expands and 2026 guidance rises, sig...
Three women chop their way into the record books at the Lumberjack World Championships in Hayward, WI, as new marks p...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
XRPL users are confronting a coordinated push of phishing and impersonation schemes, prompting warnings from Wietse W...
A historic 93% one-day rally in a well-known automaker set a record for the largest single-day stock gain, prompting ...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...